In summary, five diagnostic biomarkers (HSPA5, HSP90B1, DNAJC3, PDIA6, and HERPUD1) were identified in EMs, providing new perspectives for the diagnosis, mechanism, investigation, and management of EMs. The gene discussed is HSPA5; the disease is eosinophilia-myalgia syndrome.